Shatavarins (Steroidal Saponins · Asparagus racemosus · Female Reproductive Adaptogen)
| CAS No. | 84669-86-3 (Shatavarin I, primary marker) · 84669-84-1 (Shatavarin IV) |
| Class | Saponin · Steroidal Saponin · Spirostane-type Glycoside |
| Source | Asparagus racemosus (Shatavari / Wild Asparagus) — root (tuberous) |
| Claim strength | Moderate–High |
| Buy from Herbuno | Shatavari Powder → · Standardised Extract Powders → |
Asparagus racemosus — shatavari, or wild asparagus — occupies one of the most prominent positions in the Ayurvedic materia medica as the foremost rasayana herb for women. Its name in Sanskrit translates as "she who possesses a hundred husbands," referencing its traditional reputation as a tonic for female vitality, fertility, and reproductive longevity. The root is documented in the Charaka Samhita and Ashtanga Hridayam as a stanyajanana (galactagogue), a shukrala (reproductive tonic), and a balya (strength-promoting) herb — applications that correspond directly to the compound's modern clinical evidence base for lactation support and hormonal balance. It was prescribed across generations of Ayurvedic practice for dysmenorrhoea, menopausal symptoms, reproductive insufficiency, and postpartum recovery. In the folk medicine traditions of India, shatavari root preparations — most traditionally prepared in milk or ghee to aid absorption of fat-soluble saponins — were given to nursing mothers as a matter of routine. The plant grows wild across the tropical and subtropical regions of India, Sri Lanka, and the Himalayas. The steroidal saponins now identified as shatavarins I through IV are the molecular basis for effects that Ayurvedic physicians documented and systematised over two millennia of clinical observation.
Shatavarins are a group of steroidal saponin glycosides isolated from the tuberous roots of Asparagus racemosus. Structurally, shatavarins are spirostane-type aglycones (sarsasapogenin backbone) conjugated with oligosaccharide chains, which govern their solubility, oral absorption, and phytoestrogenic activity. Commercial shatavari extract is standardised to saponin content — typically 20–30% saponins by gravimetric or UV method, or 10–15% by HPLC — the saponin percentage distinguishes extract grades for supplement formulation from crude powders used in traditional preparations.
Shatavarins for Female Reproductive Health, Lactation Support & Adaptogenic Activity — Evidence
Female reproductive and hormonal support: Shatavarins are phytoestrogenic — they interact with oestrogen receptors and modulate luteinising hormone (LH) and follicle-stimulating hormone (FSH) signalling. Clinical and preclinical studies document improvements in menopausal symptom scores, menstrual irregularity, and perimenopause-associated discomfort with standardised shatavari root extract. The evidence base is more consistent in traditional medicine systems than in large Western RCTs, but the mechanistic rationale for phytoestrogenic activity is well-established. Claim strength: Moderate.
Galactagogue — lactation support: Shatavari is the most commercially significant galactagogue ingredient in the global lactation supplement market. Multiple clinical studies, including controlled trials, document increased prolactin levels and improved breast milk volume in postpartum women supplemented with standardised shatavari extract. This is the application with the strongest clinical translation and the clearest commercial positioning in the maternal health supplement segment. Claim strength: High.
Adaptogenic and immune-modulatory activity: Shatavarins display adaptogenic properties partly analogous to withanolides — supporting stress tolerance and immune function through modulation of cytokine profiles. Preclinical studies document enhanced natural killer (NK) cell activity and macrophage stimulation. Human adaptogenic data is less extensive than for ashwagandha but supports combination formulations positioning shatavari alongside ashwagandha for comprehensive female adaptogen blends. Claim strength: Moderate.
Digestive and gut mucosal support: Asparagus racemosus root has well-documented mucilaginous and gut-protective properties. Shatavarins contribute to mucosal lining integrity in the GI tract and have shown gastroprotective effects in ulcer models. This supports positioning in women's digestive health formulations alongside functional fibre or prebiotic ingredients. Claim strength: Moderate.
Shatavari Powder — Buy Bulk →
Browse Standardised Extract Powders →
Shatavarins Dosage, Standardisation & Formulator Specification
Clinically referenced dose: 500–1,000mg of standardised shatavari root extract per day for reproductive and lactation applications. Traditional Ayurvedic use employs whole-root powder at 3–6g per day in milk decoction — extract doses are proportionally smaller depending on standardisation level. For lactation support specifically, clinical trials have used 500mg–1g of extract twice daily. Capsule and tablet formats are the dominant delivery system; shatavari also formulates well into powder sachets and functional beverages given its relatively mild, slightly sweet organoleptic profile.
Standardisation and analytical method: Saponin content is the primary standardisation marker. HPLC-verified saponin percentage (targeting Shatavarins I and IV as primary markers) is the preferred specification for formulation. Gravimetric saponin methods, while common, are less specific — they measure foaming saponins collectively rather than shatavarins specifically and can include non-active saponin fractions. For premium product positioning or any label claim referencing specific shatavarin content, HPLC verification on the CoA is required.
Phytoestrogenic activity — formulation consideration: The phytoestrogenic activity of shatavarins is relevant to certain populations. Standard supplement label guidance recommends consultation with a healthcare provider for individuals with oestrogen-sensitive conditions. Shatavari has a long safety record in traditional medicine at conventional doses and no significant adverse event signals in clinical trials at standard supplement doses.
Pairs with: Ashwagandha (female adaptogen blend — the most commercially established pairing), Fenugreek (lactation support stacks), Maca root (hormonal balance and vitality positioning), Moringa leaf (comprehensive women's wellness formulations), Tribulus terrestris (reproductive health blends).
Frequently Asked Questions — Shatavarins
What is the difference between shatavari powder and shatavari extract?
Shatavari powder is the ground dried root — it contains the full plant matrix including fibre, starch, and a relatively low percentage of shatavarins (typically 1–3% total saponins). Shatavari extract (standardised to 20–30% saponins) concentrates the active compound class, enabling effective doses in 500mg–1g capsule formats rather than the several-gram servings required with crude powder. For supplement formulation with label claims referencing shatavari activity, standardised extract is the appropriate specification. Crude powder is suited to traditional preparation formats (churna, milk decoction) where the full food matrix is the intended delivery vehicle.
Is shatavari safe during breastfeeding?
Shatavari is used specifically as a galactagogue — a lactation-support herb — in both Ayurvedic clinical practice and an expanding body of controlled clinical research. It has a long traditional safety record in postpartum use. The clinical trial evidence for lactation support positions it as one of the better-evidenced herbal galactagogues available. As with any supplement during lactation, consultation with a healthcare provider for individual assessment is the appropriate guidance for consumer-facing label text.
Does shatavari have phytoestrogenic effects and is this relevant to hormone-sensitive conditions?
Shatavarins interact with oestrogen receptors and produce measurable effects on FSH and LH in clinical studies. This phytoestrogenic activity is the mechanism underlying their reproductive and menopausal symptom applications. For individuals with hormone-sensitive conditions, the appropriate guidance is healthcare provider consultation before use — standard language for any phytoestrogenic botanical ingredient. At conventional supplement doses, no adverse events linked to oestrogenic activity have been reported in clinical trials.
How does shatavari compare to ashwagandha as an adaptogen for women?
The two are frequently combined rather than positioned as alternatives. Ashwagandha (withanolides) has the stronger cortisol-reduction and cognitive performance evidence base applicable to both sexes. Shatavari (shatavarins) has the more specific evidence base for female reproductive health, lactation, and hormonal balance via phytoestrogenic pathways. Together they form the most commercially established dual-adaptogen pairing in the women's wellness supplement segment globally.
Claim-strength scale – High = multiple human studies; Moderate = a few trials; Emerging = early lab data.
← Back to Active Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery